Breakthrough Nano-Vaccine Developed for COVID-19

Researchers from Tel Aviv University and the University of Lisbon have created a revolutionary nano-vaccine for COVID-19, administered as a nasal spray and requiring no cold storage, SciTech Daily revealed yesterday.

This innovative vaccine effectively targets all major COVID-19 variants, utilizing synthesized amino acid sequences encapsulated in nanoparticles.

The developing researchers designed this 200-nanometer particle, which trains the immune system similarly to existing vaccines. The needle-free delivery method simplifies administration, eliminating the need for trained personnel and reducing contamination risks.

Additionally, the nano-vaccine can be stored as a powder at room temperature, overcoming the logistical challenges posed by traditional mRNA vaccines that require ultra-cold storage. This development promises to facilitate vaccination in low-income regions and could lead to the rapid creation of effective vaccines for future pandemics, marking a significant advancement in global health.